Article
In Silico Elucidation of C- and N-Domain Selectivity of Dihydropyrimidinone Derivatives as Angiotensin-Converting Enzyme Inhibitors
2026-05-25
Abstract excerpt
<title>Abstract</title> <p>Angiotensin-converting enzyme remains a clinically validated target for managing hypertension and cardiovascular disorders. Although several ACE inhibitors are widely used, their lack of domain selectivity often contributes to adverse effects. In this study, a series of designed dihydropyrimidinone derivatives were evaluated for their potential as selectivity for ACE domain through cons...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 61d590fb-d7f3-534a-a6fe-76b95e4cbfed
- DOI
- 10.21203/rs.3.rs-9516250/v1
